In this context, in order to provide ESCs, as one of the main components of the microfluidic system in modeling ALS, a transgenic mouse model has been created that provided manifestations of ALS disease by expressing the ubiquitinated cytoplasmic TDP-43 as a motor neuron-degrading agent. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.